Our Pipeline
![](https://assets-global.website-files.com/62210814b9211bd5e0ac7372/62221fdc44bbaa644bee92c4_cell-mask%20(2).png)
![](https://assets-global.website-files.com/62210814b9211bd5e0ac7372/622744794a29b9f7f51d4ee8_cell-mask.png)
![](https://assets-global.website-files.com/62210814b9211bd5e0ac7372/62221fdc44bbaa644bee92c4_cell-mask%20(2).png)
Vita aims to be a global leader in cell engineering through successful completion of clinical trials for its pipeline of programs leveraging platforms in both neuromuscular and immunotherapy.
![](https://assets-global.website-files.com/62210814b9211bd5e0ac7372/63bddbdcf8fbb5159dae79f9_Pipeline_2023JAN10.png)
![](https://assets-global.website-files.com/62210814b9211bd5e0ac7372/63bddbdca23ec58333f1ae31_Pipeline_Mobile_2023JAN10.png)
Clinical Trials
Vita Therapeutics will soon be recruiting 15 patients for a first-in-human (FIH) clinical trial of VTA-100. Please monitor this site for more details on the trial and timing.
![](https://assets-global.website-files.com/62210814b9211bd5e0ac7372/6334b494a2e0594445e3b43f_OfficeVisit.jpg)